Nuclear xenobiotic receptor PXR-null mouse exhibits hypophosphatemia and represses the Na/Pi-cotransporter SLC34A2

Yoshihiro Konno1, Rick Moore, Nobuhiro Kamiya

  • 1Pharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, North Carolina 27709, USA.

Abstract

Insights

The absence of the pregnane X receptor (PXR) causes hypophosphatemia in mice. This is due to reduced expression of the phosphate transporter gene SLC34A2, impacting bone mineral density.

Area of Science:

  • Biochemistry
  • Genetics
  • Physiology

Background:

  • The pregnane X receptor (PXR) is a nuclear receptor involved in xenobiotic metabolism.
  • Previous studies indicated that PXR deficiency leads to decreased bone mineral density (BMD).

Purpose of the Study:

  • To investigate the inherited phenotype associated with reduced BMD in PXR-deficient mice.
  • To identify PXR-regulated genes involved in bone homeostasis.

Main Methods:

  • Serum levels of phosphate, calcium, and vitamin D3 were measured in Pxr+/+ and Pxr-/- mice.
  • Gene and protein expression of transporters and bone homeostasis regulators were analyzed using RT-PCR and Western blots.
  • Reporter and gel shift assays were employed to characterize gene promoter activity.

Main Results:

  • Pxr-/- mice exhibited decreased BMD in multiple skeletal sites and hypophosphatemia (low serum phosphate).
  • The expression of the sodium-phosphate cotransporter SLC34A2 (NaPi-IIb/Npt2b) was significantly repressed in Pxr-/- mice.
  • PXR directly activates SLC34A2 transcription via an ER6 motif on its promoter.

Conclusions:

  • PXR deficiency in mice results in an inherited phenotype of hypophosphatemia.
  • Reduced expression of the NaPi-IIb/Npt2b (SLC34A2) cotransporter due to PXR absence contributes to hypophosphatemia and decreased BMD.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...